Active Epstein-barr Virus Infection
📧 Sign up to get email alerts when something new happens for Active Epstein-barr Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-20Clinical Trial Update: Rituximab Monotherapy for EBV-HLH and CAEBV [Phase 3]
Phase 3 trial update on rituximab monotherapy for EBV-associated conditions, including Secondary Hemophagocytic Lymphohistiocytosis and Chro…
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Selinexol Combined With Dexamethasone in the Treatment of CAEBV [Phase 3]
Phase 3 trial update for Selinexol combined with Dexamethasone in chronic active Epstein-Barr virus infection (CAEBV) is ongoing with status…
-
CLINICAL_TRIALS trial_result · 2018-06-01Clinical Trial Update: Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) [Phase 2]
Phase 2 trial update for reduced intensity conditioning in hemophagocytic syndromes and selected primary immune deficiencies completed with …